Investee Company – Xenocs (France)
Investee Company Business Type – Manufactures optical multi-layers for the EUV (Extreme Ultra Violet) lithography technology
Type of Financing – Early Stage
Equity Providers – Siparex Ventures and ABN Anmro Capital France
Equity Leader (Individual) – Richard Vacher-Detourniere
Debt Providers – N/A
Debt Type – N/A
Debt Leader (Individual) – N/A
Equity Amount – €3.5 million
Total Deal Value – €3.5 million
Other Advisors – PriceWaterhouseCoopers (financial), Landwell & Ass. (legal)
Comments – Xenocs, a company specialising in providing innovative solutions for the design, development and manufacture of multi-layer EUV, X-ray and neutron optics has announced a capital increase of €3.5 million to finance its growth.
The company was backed by Siparex Ventures, who led the round, and ABN Amro Capital France. Siparex committed €2.5 million and ABN Amro €1 million.
Xenocs was spun out from the Institut Laue Langevin (ILL) by Peter Hoghoj, a former researcher, and two associates. The company’s technology stems directly from research done at ILL into developing the technology of multilayer for neutrons by perfecting a production tool and by controlling the manufacturing processes. ILL has granted Xenocs the exclusive license of this tyechnology.